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Welcome to the 2012/13 Clinical Investigators’ Day sponsored by the Cornell University College of 
Veterinary Medicine. The primary goal of this forum is to provide an opportunity for residents and 
interns to showcase ongoing investigations carried out at Cornell University College of Veterinary 
Medicine.  It is our hope that greater insights will be gained in the breadth and depth of clinical 
investigations conducted at the College and will serve as a catalyst to promote greater interactions 
among colleagues with clinical and basic science research interests. 
Organizing Committee 
 
Dr. Elizabeth Buckles, Co-Chair 
Dr. Jonathan Cheetham 
Dr. Gerald Duhamel 
Dr. Ursula Krotscheck 
Dr. Mary Martin, Co-Chair 
Dr. Santiago Peralta 
Dr. Tracy Stokol 
Dr. Joseph Wakshlag, Co-Chair 
 
Support Staff 
Kim Eaton 
Dave Frank 
May Lovelace 
Stephanie Specchio 
Amy Robinson 
Judy Wood 
 
 
 
 
 
 
Cover photo credits:  Migrating cervical cancer cell stained for tissue transglutaminase, from Professor Richard 
Cerione’s laboratory, fish eggs from the Aquatic Animal Health Program, Boxer dogs from Ms. Tammy Custer, 
remaining photos from Ms. Stephanie Specchio and communications. 
 
 
Disclaimer: The information presented in this publication comes exclusively from the contributing authors and 
their mentors identified in each abstract. These abstracts are preliminary and should not be cited in bibliographies.  
Material contained herein may be treated as personal communication and should be cited as such only with the 
consent of the author. 
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We thank the following sponsors for their 
generous support and commitment to 
Clinical Investigators’ Day 
Corporate Sponsors 
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Nestlé Purina 
 
College of Veterinary Medicine  
Animal Health Diagnostic Center 
College of Veterinary Medicine Administration 
Cornell University Hospital for Animals  
Continuing Education and Events 
Department of Biomedical Sciences 
Department of Clinical Sciences 
Department of Population Medicine and Diagnostic Sciences  
Office of Research & Graduate Education 
 
College and University Programs and Units 
NIH-Supported Cornell CARE Residency Program in Laboratory Animal Medicine 
Comparative Cancer Biology Training Program 
Cornell Center for Animal Resources and Education 
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CLINICAL INVESTIGATORS’ DAY 
Lecture Hall I 
Monday, March 18, 2013 
PROGRAM 
 
8:00-8:30  Continental Breakfast (Veterinary Education Center Atrium) 
8:35-8:45  Welcome & Introductions –  Elizabeth Buckles, Mary Martin, Joseph Wakshlag 
8:45-9:05  Presentation – Key Note Speaker 
 
 “STUDIES ON THE TRANSITION PERIOD IN DAIRY COWS” 
Dr. Luciano Caixeta, Cornell Clinical Fellow 
Department of Population Medicine and Diagnostic Sciences 
 
9:05-10:20  Resident Presentations  
9:05-9:20 
 
THE EFFECTS OF SULFORAPHANE ON NEOPLASTIC CELL 
PROLIFERATION AND DEATH 
 
 Pg.1 
  Vanessa Rizzo – Medical Oncology Resident   
9:20-9:35 INVESTIGATION OF THE CHEMOPREVENTIVE EFFECTS OF 
DESLORELIN IN DOMESTIC CHICKENS WITH HIGH 
PREVALENCE OF OVARIAN CANCER 
 
 Pg. 2 
  Brendan Noonan– Exotic Animal Medicine Resident   
9:35-9:50 
 
THE 5-LIPOXYGENASE INHIBITOR TEPOXALIN, INDUCES 
APOPTOSIS AND PTEN OXIDATIVE/ALKYLATION CHANGES IN 
CANINE OSTEOSARCOMA CELLS  
 
 Pg.3 
  John Loftus – Rotating Intern   
9:50-10:05 
 
TISSUE FACTOR MEDIATES THROMBIN GENERATION IN 
CANINE CANCER CELLS 
 
 Pg.4 
  Erika Gruber–Clinical Pathology Resident   
10:05-10:20 
 
TREATMENT OF NEUROPATHIC PAIN WITH 
MICROENCAPSULATED LIDOCAINE 
 
 Pg. 5 
  Rohit Rajoria-Laboratory Animal Medicine Resident   
10:20-10:35 Break   
     
 iv 
10:35-11:50  Resident Presentations  
10:35-10:50 
 
ORAL BIOAVAILABILITY, PHARMACOKINETICS AND 
PHARMACODYNAMICS OF SINGLE DOSE INTRAVENOUS AND 
ORAL TRAZODONE IN DOGS 
 
 Pg. 6 
  Ariane Jay-Small Animal Surgery Resident   
10:50-11:05 
 
CHARACTERIZATION OF THE IMMUNE SYSTEM DURING 
EXPERIMENTAL REACTIVATION OF LATENT CANINE 
HERPESVIRUS-1 IN ADULT DOGS 
 
 Pg. 7 
  Kay Kim-Comparative Ophthalmology Resident   
11:05-11:20 The abstract of Dr. Fred Brewer has been withdrawn due to illness.   
  Fred Brewer IV-Cardiology Resident   
11:20-11:35 
 
DUCTAL PLATE MALFORMATION IN BOXER DOGS: CLINICAL 
AND HISTOPATHOLOGICAL CHARACTERISTICS 
 
 Pg. 8 
  Smitha Pankajavally Somanathan Pillai-Anatomic Pathology 
            Resident 
  
    
11:35-11:50 
 
MICE LACKING THE DNA DAMAGE RESPONSE GENE FANCD2 
ARE HYPERSENSITIVE TO LIVER DISEASE FOLLOWING HIGH 
FAT DIET FEEDING 
 
 Pg. 9 
  Elizabeth Moore-Laboratory Animal Medicine Resident   
    
11:50-12:50  Lunch & Presentations  Career Opportunities in Research beyond Resident Training 
   
 “GRADUATE TRAINING PROGRAM IN COMPARATIVE MEDICINE” 
Dr. John Parker 
Associate Professor of Virology 
Baker Institute for Animal Health 
 
“RESEARCH AND TRAINING OPPORTUNITIES BEYOND YOUR RESIDENCY” 
Dr. Joel Baines 
James Law Professor of Virology 
Associate Dean for Research and Graduate Education 
Department of Microbiology and Immunology 
 
“PANEL DISCUSSION ON CAREER PATHS” 
Dr. Jon Cheetham, Dr. Erin Daugherity, and Dr. Joseph Wakshlag 
Research Scientists, Clinical Veterinarian, Associate Professor of Clinical Nutrition 
 
   
 v 
12:50-1:35 Resident Presentations  
12:50-1:05 
 
EVALUATING THE EFFICACY OF A LOW-DOSE GARLIC COMPOUND 
AGAINST AEROMONAS SALMONICIDA IN RAINBOW TROUT 
 
Pg. 10 
  Kate Breyer – Laboratory Animal Medicine Resident  
1:05-1:20 
 
EFFECT OF A PROXIMAL ABDUCTING ULNAR OSTECTOMY ON INTRA-
ARTICULAR PRESSURES OF THE CANINE ELBOW EX VIVO 
 
Pg. 11 
  Marina McConkey-Small Animal Surgery Resident  
1:20-1:35 
 
THE HERITABILITY OF TONGUE LOLLING IN DAIRY CATTLE 
 
Pg. 12 
  Whitney Knauer-Ambulatory and Production Medicine Resident  
1:35-1:50 
 
Break  
1:50-2:35 Resident Presentations  
1:50-2:05 
 
The abstract of Dr. Fred Brewer has been withdrawn due to illness.  
  Fred Brewer IV-Cardiology Resident  
2:05-2:20 CLINICAL AND SEROLOGIC DIAGNOSIS OF BESNOITIOSIS IN 
DONKEYS 
Pg. 13 
  SallyAnne Ness-Large Animal Internal Medicine Resident  
2:20-2:35 
 
LONG-TERM FUNCTIONAL OUTCOME OF TPLO VERSUS 
EXTRACAPSULAR REPAIR IN A HETEROGENEOUS POPULATION OF 
DOGS 
 
Pg. 14 
  Samantha Nelson-Small Animal Surgery Resident  
2:35-2:55 Presentation – Key Note Speaker 
 
 
“MAKING FLUFFY’S DAMAGED DNA CURE HER CANCER” 
Dr. Kelly Hume, Assistant Professor, Section of Oncology 
Department of Clinical Sciences 
 
    
2:55-4:00 Reception and Awards Presentation  
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Key Note Speakers 
 
 
Luciano Souza Caixeta, DVM, Cornell Clinical Fellow.  After graduating from 
veterinary college at the Federal University Goiás, Brazil, Dr. Caixeta completed a 
residency in ambulatory and production medicine at Cornell University.   As a 
Clinical Fellow, he is beginning his graduate studies under the mentorship of Dr. 
Nydam in the Department of Population Medicine and Diagnostic Sciences and Dr. 
Yves Boisclair in the Department of Animal Science. He is studying metabolic 
regulation and clinical nutritional management of transition dairy cows.  
 
 
Kelly Hume, DVM, DACVIM (Oncology), Assistant Professor, Section of 
Oncology, Adjunct Assistant Professor, Department of Biomedical Sciences. 
Dr.  Hume received her DVM, Cum Laude, in 2003 from Auburn University and 
received her Board Certification in Veterinary Internal Medicine, Specialty 
of Oncology, in 2008.  She completed her three-year residency at North Carolina 
State University prior to receiving one of the first Cornell Clinical Fellows awards 
made in 2008.  Dr. Hume’s long term goals are to interact with clinician and basic 
scientists at all levels of cancer biology, recognizing the need to marry the two vital 
tracks.    Mentoring and teaching undergraduate students, graduate students, and oncology residents 
in both clinical and molecular oncology is one of Dr. Hume’s overarching career goals. 
 
Moderators 
Susan L. Fubini, DVM, Professor of Large Animal Surgery, Department of 
Clinical Sciences. Dr. Fubini received her DVM in 1980 from the University of 
Georgia and received her Board Certification in Veterinary Surgery in 1987. She 
completed her three-year intern and resident training at Cornell University prior to 
joining the College faculty.   She is currently a member of the College of Veterinary 
Medicine’s College Research Council and was recently named the Associate Chair 
for Promotion, Tenure, and Mentoring in the Department of Clinical Sciences.  Dr. 
Fubini has mentored over 50  interns and residents since her tenure at the College and in 1990 
received the Norden Distinguished Teacher of the Year award.   
 
Dave Lin, Ph.D. Associate Professor of Neurobiology, Department of Biomedical 
Sciences.   Professor Lin received his Ph.D. in 1994 from the University of 
California at Berkeley. He joined the college faculty in 2001 and also served as the 
Director of the Microarray Core from 2004-2010.  Dr. Lin is the Director of 
Graduate Studies for Comparative Biomedical Sciences and of Genomics. He is a 
member of the following graduate fields:   Molecular & Integrative Physiology; 
Pharmacology; Biochemistry, Molecular & Cell Biology; Genetics, Genomics and 
Development; Genomics; and Neurobiology & Behavior. Additionally, Dr. Lin is a member of the 
Dual Degree (DVM/PhD) Oversight Committee and Biological and Biomedical Sciences Graduate 
Program Oversight Committee.  His laboratory focuses on the development of the nervous system 
using the mouse olfactory system as a model.  
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Moderators (Continued) 
 
 
Carolyn S. Sevier, Ph.D. Assistant Professor, Department of Molecular 
Medicine. Dr. Sevier received her Ph.D. in 1999 from Johns Hopkins School of 
Medicine. She completed her postdoctoral training at the Massachusetts Institute of 
Technology and was then subsequently appointed as a Research Scientist in 
2004. During her postdoctoral training, Dr. Sevier was also awarded a three-year 
NIH National Research Service Award. Her research accomplishments center on 
elucidation of the fundamental molecular mechanisms used by cells to efficiently 
fold, process, and traffic proteins. She joined the faculty at the College of Veterinary Medicine in 
2010.  
 
Speakers 
 
Joel Baines, VMD, Ph.D., James Law Professor Virology, Department of 
Microbiology and Immunology, and Associate Dean for Research and Graduate 
Education. Dr. Baines received the VMD degree from the University of 
Pennsylvania in 1983. He then received his PhD from Cornell University in 1988, 
studying the molecular virology of feline coronaviruses. The Baines’ laboratory is 
focusing on the molecular basis of herpesvirus assembly as it pertains to the 
discovery of antiviral targets. His work has been continuously supported by the NIH since 1995.  He 
is also Director of the Veterinary Investigators Program (VIP) and the Cornell Clinical Fellows 
Program. 
 
 
John S. Parker, BVMS, Ph.D., Associate Professor of Virology.   Dr. 
Parker received his veterinary degree from Glasgow University, Scotland, 
in 1983, and practiced clinical veterinary medicine for 11 years prior to 
pursuing a Ph.D. at Cornell University.  He continued his postdoctoral 
training at Cornell and at the Harvard Medical School before returning to 
Cornell as faculty member of the Baker Institute for Animal Health.   In 
2005, Dr. Parker received the prestigious Burroughs Wellcome Fund award for “Investigators in 
Pathogenesis of Infectious Disease” and has had continuous grant support from sponsors such as the 
Cornell Feline Health Center, Morris Animal Foundation, NIH, and US-Israel Binational 
Agricultural Research Development Fund.   Dr. Parker is an active teacher and strong mentor to 
veterinary students and veterinarians seeking advanced degree training.  He is the Director of the 
Cornell University Leadership Program for Veterinary Students and Director of the Graduate 
Training Program in Comparative Medicine, both supported by the NIH and other sponsors.    
 
Jon Cheetham, VetMB, MA, DipACVS, Ph.D. Research Scientist, Department of 
Clinical Sciences.  Dr. Cheetham is a 1995 graduate of the Cambridge University 
Veterinary School where he received his MA degree in Medical Sciences and a 
VetMB in Veterinary Medicine.  His work focuses on restoring function in the 
larynx, nasopharynx and trachea using tissue engineering, reinnervation and 
functional electrical stimulation techniques.  The lab's research is applied to both 
human and veterinary patients.  Dr. Cheetham is board certified by the American 
College of Veterinary Surgeons and holds a Ph.D. from Cornell. 
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Speakers (Continued) 
 
Erin Daugherity, DVM, Clinical Veterinarian, Cornell Center for Resources and 
Education.  Dr. Daugherity graduated with a B.S in Animal Science from Cornell 
University in 1997. After spending two years working as a research associate at the 
University of Wisconsin-Madison, McArdle Laboratory for Cancer Research, she 
attended veterinary school at the University of Wisconsin-Madison and received her 
DVM in 2007. She then returned to Cornell University to complete a residency in 
laboratory animal medicine with the Center for Animal Resources and Education 
(CARE). As a resident, she joined the Robert Weiss Laboratory and completed a Clinical Fellowship 
in October 2012. Her research focuses on fatty liver disease and its progression to hepatocellular 
carcinoma. Dr. Daugherity is now a Clinical Veterinarian at Cornell, with continued work in the 
Weiss Lab. 
 
Joseph Wakshlag, MS, DVM, Ph.D., Associate Professor of Clinical Nutrition, 
Department of Clinical Sciences.  Dr. Wakshlag has been a member of the 
college faculty since 2006. He received his DVM at Cornell University and 
continued his residency training in Pathology and Nutrition at Cornell and 
subsequently received his Ph.D. in Pharmacology in 2005.    Dr. Wakshlag is also 
the head of the nutrition and obesity management services in the college.  He 
serves on a number of college and university committees, such as the Institutional 
Animal Care and Use Committee, Clinical Sciences Research Committee, College 
Research Council, serves as a mentor to trainees at all levels, including veterinary and graduate 
students, interns and residents, and postdoctoral fellows, and has an active clinical research program. 
 
Judges 
Bruce Akey, MS, DVM, Assistant Dean for Diagnostic Operations and Executive 
Director Animal Health Diagnostic Center College of Veterinary Medicine.    Dr. 
Akey provides overall leadership and management of the Animal Health Diagnostic 
Center and the over 240 employees therein. The Center’s clients span all 50 states as 
well as federal and international clients. Prior to joining the College of Veterinary 
Medicine in 2006, Dr. Akey served as the Assistant State Veterinarian of the New 
York State Department of Agriculture-Division of Animal Industry from 2003-2006 
and from 1990-2003 he was Chief, Office of Laboratory Services Virginia Department of 
Agriculture and Consumer Services, Division of Animal Industry Services.   He received his Masters 
of Science from the University of Florida in parasitology and his DVM from the University of 
Minnesota, in 1981 and 1987, respectively.    
 
Kei Hayashi, DVM, PhD, Dipl.ACVS,  Associate Professor, Department of 
Clinical Sciences.   Dr. Hayashi joined the College faculty in February 2013 as a 
small animal orthopedic surgeon.  Dr. Hayashi graduated from the University of 
Tokyo, Veterinary Medical Science in 1993 with a focus in small animal medicine 
and surgery and a post-doctoral degree in Veterinary Medical Science in 1997. 
Concurrently he also completed a post-doctoral degree in Comparative Biomedical 
Sciences at the University of Wisconsin. He then completed a fellowship in Small 
Animal Medicine and Surgery and a residency in Small Animal Surgery at the University of 
Wisconsin in 2003. His areas of expertise include all aspects of orthopedic surgery and minimally 
invasive surgery. Dr. Hayashi has numerous research publications, and has contributed to text book 
chapters in the field of small animal surgery. 
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Judges (Continued) 
 
 
Sean McDonough, DVM, DipACVP, Ph.D., Associate Professor, Section of 
Anatomic Pathology, Department of Biomedical Sciences. Dr. McDonough 
obtained his DVM from Colorado State University in 1981 and engaged in small 
animal medicine in central Wyoming. Dr. McDonough entered the veterinary 
pathology residency program at the University of California, Davis in 1989 and 
achieved diplomate status in the American College of Veterinary Pathology in 
1992. The Ph.D. in Comparative Pathology was awarded by the University of 
California, Davis in 1996.  Dr. McDonough has been instrumental in leading the 
College’s Residency Program in Anatomic Pathology.  He has collaborated extensively with faculty 
and scientists throughout the world focusing on research of disease pathogenesis and gene function 
and genomics to help bridge the link between animal diagnostics and experimental biology.  His 
personal research interests are to employ use of contemporary methods to explore immune function in 
spontaneous veterinary disease. 
 
Bhupinder Singh, DVM, Board Certified in the American College of 
Laboratory Animal Medicine, Clinical Veterinarian, Cornell Center for Animal 
Resources and Education (CARE).   Dr. Singh received his Master of Veterinary 
Science degree from Punjab Agricultural University in 1996, and his Educational 
Commission on Foreign Veterinary Graduates Certificate from Cornell in 2004. 
After a post-doctoral residency in Laboratory Animal Medicine at Yale, joined 
CARE in July 2007.  He is a member of the American Society of Laboratory 
Animal Practitioners and American Association for Laboratory Animal Science.   
 
 
David Way, Associate Director, Center for Teaching Excellence.    Dr. Way has 
helped initiate college-wide graduate teaching development programs within the 
University, developed training and educational materials used throughout the 
university, and assisted colleges to redesign their student evaluation of teaching 
systems.  He initiated and published the first university-wide newsletter on 
undergraduate education, has consulted with over 30 departments and academic 
fields on instructional and faculty development, and has been instrumental in the 
design and development of an annual faculty retreat on teaching and learning.  
Dr. Way teaches “Teaching in Higher Education” and is the author of the Cornell Teaching 
Evaluation Handbook.   He has been involved in the University Self-Study Working Group on 
Assessment of Student Learning and on the Vice Provost for Undergraduate Education's Core 
Assessment Committee. Dr. Way is also the Center for Teaching Excellence Liaison for the College 
of Veterinary Medicine.  He has facilitated several educational workshops and seminars on effective 
communications skills for students, residents, staff, and faculty in the College during his more than 
30 year tenure at Cornell. 
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Name/Degrees: Vanessa Rizzo, DVM         
 
Email: vlr33@cornell.edu 
 
Institution and location (Chronological)   Degree  Year 
Western University of Health Sciences, Pomona CA DVM  2010 
Cornell University, Ithaca NY    Residency 2011- 
present 
Current Position: Resident, Medical Oncology - 2nd year 
 
Abstract Title:  THE EFFECTS OF SULFORAPHANE ON NEOPLASTIC CELL 
PROLIFERATION AND DEATH 
 
Authors Names:  Vanessa L. Rizzo, Cornell University; Joseph Wakshlag, Cornell University; 
Jessica Chandler, Cornell University 
 
Project Mentor(s): Joseph Wakshlag, Department of Clinical Sciences (Mentor), Kelly Hume, 
Department of Clinical Sciences (Co-mentor), Robert Weiss, Department of Biomedical 
Sciences (Co-mentor) 
 
Abstract:  
Introduction: Recent evidence in human cancer patients and rodent models suggests that the 
neutraceutical sulforaphane (typically found in raw cruciferous vegetables) may have utility in 
prevention of cisplatin induced renal toxicity, however there is little examination on its effects 
on cancer cells with or without conjunctive chemotherapeutics.  
 
Methods: To examine the potential safety and effects on canine cancer cells three canine cell 
lines were treated with a serial dilution of sulforaphane (0-50 uM) for 48 hours and 6 day 
growth curve assays were performed using MTT assays. Apoptosis was examined using 
annexin V staining, or caspase 3 immunoblotting. Further viability assays were performed to 
examine sulforaphane treatment in conjunction with either palladia (mast cells) or doxorubicin 
(osteosarcoma). Statistical analysis was performed using analysis of variance with Tukey’s 
post hoc analysis or Student’s T test to determine significance.  
 
Results: Results suggest that all cell lines have reduced cell viability in both the 48 hour MTT 
proliferation and the growth curve analysis at between 2 and 3 uM of sulforaphane (p < 0.05) 
with apoptosis occurring in two of the three cell lines (mast cells and osteosarcoma cells) at 
concentrations between 10-20 uM. Sulforaphane did not promote cell survival nor did it 
promote further cell death in the face of other chemotherapeutic insults in mast or 
osteosarcoma cells.  
 
Conclusion: Further mechanisms for reduced cell viability are being examined, however 
sulforaphane does not confer a survival advantage for these cell lines making it a potential 
neutraceutical to investigate for chemotherapy-induced renal cytotoxicity. 
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Name/Degrees: Brendan Noonan, DVM       
 
Email: bpn3@cornell.edu  
 
Institution and location (Chronological)  Degree  Year 
Cornell University, Ithaca NY   DVM  2009 
Broward Avian and Exotic Animal Hospital, FL Internship 2009-2010 
Cornell University College of Veterinary Medicine Residency 2011-present 
 
Current Position: Resident, Exotic Animal Medicine – 3rd year 
 
Abstract Title:  INVESTIGATION OF THE CHEMOPREVENTIVE EFFECTS OF DESLORELIN  
IN DOMESTIC CHICKENS WITH HIGH PREVALENCE OF OVARIAN CANCER 
 
Authors Names:  Brandan Noonan,1 Elizabeth Buckles,2 Alexander Nikitin,2 Patricia Johnson,3 Ricardo 
de Matos1 
 
1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University 
2Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University 
3Department of Animal Sciences, College of Agriculture and Life Sciences, Cornell University 
 
Project Mentors: Ricardo de Matos (mentor), Alexander Nikitin (co-mentor) 
 
Abstract: 
The domestic chicken is the only naturally occurring model of human ovarian cancer. The goals of the 
study were to: 1) evaluate safety and efficacy of deslorelin implants in inhibiting egg laying activity, and 
2) evaluate cancer prevention properties of deslorelin implant in a strain of domestic chickens with high 
prevalence of ovarian cancer. Thirty actively laying 2 year old chickens were randomly assigned to 1 of 
3 groups (10 birds per group): 1) placebo, 2) 4.7mg or 3) 9.4mg deslorelin implant. All birds were 
evaluated (weight, ultrasound examination of the reproductive tract) weekly for one month and once a 
month after for 12 months. Egg laying activity was recorded daily. Within two weeks of implant 
application, 100% of the birds with drug implant presented suppressed ovary activity. All placebo birds 
continued to lay eggs and presented normal follicular activity on ultrasound examination. The mean 
duration of inhibition was 180 days for the 4.7mg group and 319 days for the 9.4mg group. After 12 
months, a second implant was placed in 50% of the remaining birds in each treatment group. Monitoring 
was as described above for an additional 10 months. Postmortem exam was performed in all birds 
euthanized or that died during the study period. After 22 months of observation, ovarian cancer incidence 
was 50% for the placebo group, 10% for the 4.7mg group and 0% for the 9.4mg group. This data suggests 
chemopreventive effect of deslorelin in a strain of domestic chickens with high incidence of ovarian 
cancer. 
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Name/Degrees:   John Loftus, DVM       
 
Email: jpl249@cornell.edu 
 
Institution and location (Chronological)             Degree  Year 
University of Massachusetts, Boston MA  Ph.D.  2008 
Cornell University, Ithaca, NY    DVM  2012 
 
Current Position:   Rotating Intern 
 
Abstract Title:   THE 5-LIPOXYGENASE INHIBITOR TEPOXALIN, INDUCES APOPTOSIS 
AND PTEN OXIDATIVE/ALKYLATION CHANGES IN CANINE OSTEOSARCOMA 
CELLS  
 
Authors Names:  John Loftus, Derek Cavatorta, Carolyn Sevier, Joseph Wakshlag - Cornell 
University College of Veterinary Medicine, New York 
 
Project Mentor:   Joseph J Wakshlag, Department of Clinical Sciences  
 
Abstract:  
5-Lipoxygenase (5-LOX) inhibition has been shown to induce apoptosis in many epithelial cell 
lines; however, their utility in cancer has not been fully elucidated due to observed side effects 
in-vivo. Though various inhibitors of 5-LOX have been examined in epithelial cells, relatively 
little work has been performed on other cell lines including round cell or sarcoma cells. 
Considering the utility and common use of the 5-LOX inhibitor tepoxalin in veterinary 
medicine, we chose to examine the utility of this unique dual 5-LOX/COX inhibitor using 
canine osteosarcoma cell lines as a model to determine if tepoxalin was cytotoxic to three 
different canine osteosarcoma cell lines. Results suggest that tepoxalin, but not its COX 
inhibiting metabolite (RWJ20142), is cytotoxic and can induce apoptosis in all OSA cell lines 
examined between 1-10 M, with varying sensitivity as observed through caspase 3 activation 
and annexin staining. Interestingly, apoptosis is superseded by oxidative damage induced by 
tepoxalin as measured by activation of dihydrorhodamine 123 and mitosox, but not the COX 
inhibiting metabolite (RWJ20142). Additionally, 5-LOX inhibition by tepoxalin appears to 
allow phosphagen and tensin homolog (PTEN) activation by either altering alkylation or 
oxidation, which diminishes its ability to inactivate phosphoinositide-3-kinase thereby 
heightening activation of protein kinase B (AKT) phosphorylation prior to the apoptotic 
response, suggesting that oxidation is the major mechanism for tepoxalin’s cytotoxic effects, 
while lipoxygenase inhibition might also play a role through protein alkylation changes. 
 
 
 
 
 4 
 
Name/Degrees: Erika Gruber, DVM      
  
Email: ejg33@cornell.edu 
 
Institution and location (Chronological)   Degree  Year 
Cornell University, Ithaca, NY    DVM  2006 
Colorado State University, Ft. Collins, CO  Internship 2007 
Cornell University      Residency 2013 
 
Current Position: Resident, Clinical Pathology, 3rd year 
 
Abstract Title:  TISSUE FACTOR MEDIATES THROMBIN GENERATION IN CANINE 
CANCER CELLS 
 
Authors Names:  Erika Gruber, Cornell University; James Catalfamo, Cornell University;  
Tracy Stokol, Cornell University. 
 
Project Mentor: Tracy Stokol, Department of Population Medicine and Diagnostic Sciences 
 
Abstract: (< 250 words) 
Hypercoagulability is a recognized paraneoplastic syndrome in dogs and humans. Tissue factor 
(TF), the main activator of coagulation, is upregulated in numerous human and canine cancers 
and may play a role in altered hemostasis in these disorders. Furthermore, TF and thrombin, a 
product in the coagulation cascade, both engage in cell signaling pathways that influence 
tumor growth and metastasis. We hypothesized that high-TF expressing cells from a canine 
mammary tumor (CMT25) would generate more thrombin than low-TF expressing cells from a 
canine osteosarcoma (HMPOS). Thrombin generation potential (TGP) of suspended cells was 
measured with a kinetic assay using microparticle-free canine or human plasma and a 
fluorogenic thrombin-specific substrate, with no additional trigger or phospholipid reagents. 
Compared with HMPOS, CMT25 cells had shorter lag time (average 3.1 versus 6.9 minutes, 
p=0.045; unpaired t test) and greater thrombin generation (average area under the curve, 3693 
versus 809 nM*minutes, p=0.009). TGP of CMT25 cells was markedly reduced in human 
factor VII-deficient plasma compared to human control plasma. TGP of CMT25 cells was 
independent of contact activation since it was unaffected by corn trypsin inhibitor (CTI) or 
factor XII deficiency. In contrast, TGP of HMPOS cells was inhibited by CTI. We conclude 
that TGP is driven largely by TF expression in the two evaluated cancer cell lines. Since TF 
and thrombin have roles in cancer biology independent of thrombosis, characterization of their 
expression and activity in specific tumors may lead to the development of novel therapeutic 
agents targeting these proteins in canine cancer patients. 
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Name/Degrees: Rohit Rajoria, DVM       
 
Email: rr427@cornell.edu 
 
Institution and location (Chronological)   Degree  Year 
St. George’s University, Grenada, West Indies  DVM  2011 
Cornell University, Ithaca New York             Residency  Current 
 
Current Position: Resident, Laboratory Animal Medicine – 2nd  year 
 
Abstract Title:  TREATMENT OF NEUROPATHIC PAIN WITH MICROENCAPSULATED 
LIDOCAINE 
 
Authors Names:     Rohit Rajoria1, Bhupinder Singh1, Teresa Southard2, L Masinde3, Todd Pavek1 
 
1Center for Animal Resources and Education (CARE), Cornell University, Ithaca, NY 
2College of Veterinary Medicine: Biomedical Sciences, Cornell University, Ithaca, NY 
3Capsulated Systems, Inc., Yellow Springs, OH 
 
Project Mentor: Todd Pavek, DVM, DACLAM. 
 
Abstract:   
Neuropathic pain (NPP) is a type of chronic pain that can result from numerous medical conditions 
whether localized or systemic.  NPP is characterized by exaggerated responses to painful (hyperalgesia) 
and non-painful stimuli (allodynia) that frequently becomes a chronic condition leading to progressive 
reduction in quality of life.  The goal of this study is to assess effectiveness and duration of effect for 
locally and systemically administered lidocaine prepared in sustained release formulation 
(MicroEncapsulation; ME).  The ME substance used to encapsulate the lidocaine is the primary 
component of commonly used absorbable sutures. 
 
A commonly accepted model of NPP, known as Chronic Constrictive Injury (CCI), leads to a normal 
inflammatory process through constrictive ligature with chromic gut suture which acts as a potent 
irritant to the sciatic nerve of the rat. This peripheral neural irritation results in a reduced pain and 
mechanical irritation threshold for the dermatomes supplied by the sciatic nerve. Two common methods 
for objective measurement of NPP are: 1) pain threshold reduction (thermal withdrawal latency-TWL); 
and 2) presence of allodynia (Von Frey fiber apparatus- VFTS).  Preliminary data (n=7) suggest that 
extended relief of NPP results from one intraoperative dose of ME lidocaine (MEL) at days 5, 7, and 10.  
However, systemic administration of MEL does not appear to provide relief of NPP at any time point so 
far.  This study provides objective parameters to identify an appropriate method and dose for ME 
lidocaine that can provide adequate analgesia for a longer duration (vs. standard lidocaine) in cases of 
NPP.   
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Abstract: 
Objective: To determine absolute bioavailability(%F), pharmacokinetics, and pharmacodynamics of 
trazodone in healthy dogs following IV and oral administration.  
Animals: 6 beagle dogs. 
 
Procedures: Dogs received trazodone HCl at 8mg/kg orally and intravenously in a randomized 
controlled crossover design. Blood samples were collected prior to drug administration and at 5, 15, 30, 
60, 120, 240, 480, 720, 1080, and 1440 minutes. Heart rate, blood pressure, anxiety score, and sedation 
score were obtained. Plasma trazodone concentrations were determined by ultra-high performance liquid 
chromatography. Data were subjected to non-compartmental analysis with area under the time-
concentration curve calculated using the trapezoidal model. Additional variables determined were 
elimination half-life(t½), plasma total body clearance(ClT), apparent volume of distribution(Vd), mean 
residence time(MRT), maximum plasma concentration(Cmax), and time to maximum plasma 
concentration(Tmax). 
 
Results: Following IV administration the mean±SD t½, Vd, ClT were 169 ± 53 min, 2.53±0.47 L/kg, 
and 11.15±3.56 ml/min/kg, respectively. Following oral administration the mean±SD t½ and %F were 
166 ±47 min, and 84.6±13.2%, respectively. Cmax following oral administration was 1.3±0.5 ug/ml, 
and Tmax was 445±271 min. After IV administration all dogs experienced immediate transient 
tachycardia (184.3±8.0 bpm), and 3/6 dogs experienced aggression. Increase in heart rate was 
significantly associated with increase in drug level following IV administration. Sedation and anxiety 
scores were not significantly correlated with drug level. 
 
Clinical Relevance: Oral administration results in acceptable %F, though Tmax is highly variable. 
Individualized approaches in dosing intervals may be necessary for dogs receiving trazodone. Oral doses 
of 8mg/kg trazodone are well tolerated in dogs. 
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Abstract:  
Purpose. To characterize the immune status during canine herpesvirus-1 (CHV-1) reactivation 
in latently infected dogs.  
 
Methods. Adult beagles with experimentally induced CHV-1 latent infections were 
administered a viral reactivation stimulus (prednisolone 3mg/kg orally once daily for 7 days). 
All dogs had complete ophthalmic examinations performed every 3 days for the duration of the 
30 day study. Conjunctival swab and blood samples were collected at intervals for CHV-1 
PCR, CHV-1 neutralizing antibody titers, complete blood counts, lymphocyte phenotyping and 
proliferation assays, and interferon gamma (IFN-gamma) production in vitro.  
 
Results. Clinical examination revealed abnormalities consistent with recurrent CHV-1 ocular 
disease in all 10 dogs by study day 6. Ocular CHV-1 shedding was detected by PCR in three 
dogs (30%) between study days 9 and 15. CHV-1 neutralizing antibody titer elevations (1.5 to 
4-fold) were detected in 7 dogs (70%) by study day 15. Median lymphocyte count did not vary 
during the study period. Proportion of lymphocytes expressing CD4, CD8, CD21, and MHC 
class I and II markers increased by study day 7, and returned to baseline values on study days 
14 and 21. Lymphocyte proliferation index and IFN-gamma production in vitro were 
maintained during the study period.  
 
Conclusions. Viral reactivation was achieved using immunosuppressive therapy; however, 
immunologic testing did not reveal an expected systemic immunosuppression. These findings 
contrast with previous publications that indicate a direct effect of prednisolone on lymphocyte 
number, distribution and function in dogs. It is possible that concomitant viral reactivation 
changes the systemic immunologic effect of the immunosuppressive agent. 
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Abstract:   
Ductal plate malformations (DPM) reflect persistence of excess embryonic biliary structures 
and fibrosis in portal tracts. We suspected predisposition of Boxer dogs for DPM based on 
biopsy submissions to the Section of Anatomic Pathology.  
 
Methods: Electronic databases (1996-2012, College of Veterinary Medicine) identified 110 
Boxers; n=10 with DPM. Digitally scanned slides stained with H&E and Masson's trichrome 
were used to quantify portal expansion and fibrillar collagen; DPM dogs were compared to 
age-matched Boxer controls (n=5, Wilcoxon rank sum test, P<0.05). Immunohistochemical 
analyses used antibodies against Cytokeratin 19 (CK19) and collagen IV.  
 
Results: Incidence was 9.1%, without gender predisposition, presenting age was 1.0 (0.3-1.7) 
and survival was 6.5 (0->10) years. Clinical features included gastrointestinal signs, weight 
loss, and increased liver enzymes. Most livers were grossly normal or finely nodular. Portal 
tracts were markedly expanded/bridged with collagen with intact limiting plates. Numerous 
bizarre dilated bile ducts, hyperplastic arterioles, and occasional inflammatory infiltrates were 
present in portal tracts. DPM portal tract area (9.8% [5.2-17.8]) was significantly higher than 
controls (3.7% [3.0-5.2]), P=0.05. Fibrillar collagen was increased (not significantly, P=0.09). 
Ductular epithelium was normal and well differentiated having strong CK19 immunoreactivity. 
Portal tracts exhibited strong type IV collagen immunoreactivity.  
 
Conclusion: DPM Boxers present early (<2 yrs), have vague gastrointestinal signs or 
increased liver enzymes, and may survive >10 years. Histopathological features recapitulate 
those described in humans including: >2.5-fold expansion of portal tracts, increased type I and 
IV collagens, strong CK19 immunoreactivity (well differentiated biliary epithelium) and type 
IV collagen (fetal collagen) in portal tracts.  
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Abstract:  
Introduction: Fanconi anemia (FA) is a phenotypically and genetically heterogenous genomic 
instability disease affecting 1 in 131,000 people in the United States, with 1 in 181 people 
being heterozygous at an FA locus. The FA pathway consists of at least 15 genes and responds 
to polymerase blocking lesions. FA phenotypes include developmental defects, cancer 
predisposition, and increased susceptibility to genetic stress. The endogenous sources of DNA 
damage to which FA-deficient cells are sensitive are poorly understood. We employed a 
Fancd2-/- mouse model to test the hypothesis that lipid oxidation products are a source of 
endogenous damage repaired by the FA pathway.  
 
Methods: Fancd2-/- and control mice were placed on a standard diet (SD) or a high fat diet 
(HFD) at weaning for 8 or 12 weeks. Complete blood counts, serum chemistries, and liver and 
body weight were analyzed. Histological sections were scored for cellular and nuclear atypia, 
fibrosis, vesiculation, and bile duct hyperplasia. TUNEL was utilized to quantify apoptosis, 
and hepatic expression of DNA damage response genes was quantified by qPCR.  
 
Results: HFD fed Fancd2-/- mice had elevated liver enzymes, increased bile duct hyperplasia, 
elevated hepatic apoptosis, and increased expression of the DNA damage response gene p21 
compared to HFD fed Fancd2+/+ controls.  
 
Conclusion: Fancd2-/- mice have more severe HFD-induced hepatic pathology, and increased 
expression of DNA damage response genes compared to controls. These results suggest that 
Fancd2-/- mice are deficient in repairing HFD induced damage and have important 
implications for dietary management of FA patients.  
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Abstract:  
Nutritional supplements have long been used to increase immunity and thereby decrease rates 
of disease in many species; this may be especially important in aquatic medicine, where 
antibiotic usage is limited. Allicin, the active component in garlic, has proven antimicrobial 
activity against many pathogens and may upregulate non-specific immune defenses. The 
purpose of this study was to determine if allicin is a safe and effective feed supplement to 
promote immunity and survival among young rainbow trout (Oncorhynchus mykiss) 
challenged with a modified LD50 dose of Aeromonas salmonicida (furunculosis). Hypotheses 
were 1) fish fed allicin would have increased survivability against challenge with A. 
salmonicida, and 2) those fed the highest allicin dose would have the best survivability. Fish 
were fed diets containing 0%, 0.5%, 1.0% and 2.0% allicin for 14 days prior to bacterial 
challenge and were then monitored for morbidity and mortality for 28 days post-infection. 
Significant (p<0.05) increases in survival were noted in the 0.5% and 1.0% groups with 
decreased survival in the 2.0% group. Quantitative PCR sampling, to determine if systemic 
bacterial loads varied with allicin dose, will be performed in the future. Though the 
mechanism is not yet well understood, it appears that a low-dose (0.5%) supplementation with 
allicin may promote survivability in fish challenged with A. salmonicida and may be a useful 
feed additive to promote immunity in intensive aquaculture settings. 
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Abstract: 
Introduction: The ALPS (Advanced Locking Plate System) Proximal Abducting Ulnar Osteotomy 
(PAUL) plate was developed to treat medial compartment disease (MCD) by unloading the medial 
compartment of the elbow joint. Intra-articular pressure distributions in incongruent (short radius) 
canine elbows were measured after placement of a PAUL plate. We hypothesized the PAUL plate would 
reduce pressure in the medial compartment.  
 
Methods: The medial and lateral elbow compartments of cadaveric limbs were instrumented with thin-
film sensors (n=6). A 200N cyclic force with a 20 second hold was applied to each limb. Contact area 
(CA), mean contact pressure (mCP), and peak contact pressure (pCP) were then determined at this point, 
after shortening the radius 1.5mm, and after sequential placement of 2 and 3mm PAUL plates. Paired t-
tests were used to compare the treatment to normal with a bonferroni correction (p<0.017 was 
significant) 
 
Results: The creation of an incongruent elbow decreased the CA and increased the mCP in the medial 
compartment of the elbow joint (p=0.010, p=0.008). The placement of the 2mm PAUL plate decreased 
CA and pCP in the medial compartment (p=0.002, p=0.016) while the 3mm PAUL plate decreased CA, 
mCP, and pCP in the medial elbow compartment (p=0.002, p=0.001, p=0.006 ).  
 
Conclusion: An incongruent canine elbow has decreased medial contact area and increased medial 
contact pressure compared to the normal elbow. The PAUL plate significantly decreases contact area, 
and mean and peak contact pressure in the medial elbow compartment and may be an effective treatment 
for MCD.  
 
Acknowledgements:   Supported by a Canine Health Foundation ACORN grant. All implants 
provided by KYON Pharma Inc. 
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Abstract:  
Introduction: 
The most common stereotypy in dairy cattle is tongue lolling. It can develop in calves as early 
as ten days old. Restraint, feed restriction and isolation all have been shown to contribute to 
its development in heifers and lactating dairy cattle. Given the same environment, it still 
remains unclear why some animals develop tongue lolling behavior and others do not. The 
goal of this study was to investigate the heritability of oral stereotypy behavior in adult dairy 
cattle.  
 
Materials and Methods:  
Over a year time period during routine visits to one large predominantly Holstein dairy, 
animals that were observed to be tongue lolling were recorded. Sire information was retrieved 
from computer records.  
 
Results:  
A total of 96 cows were identified as positive for tongue lolling of which 93 had their sire 
recorded. A chi square test of independence between sire and tongue lolling indicated lack of 
independence (p<.001). A further analysis was performed by including the sire of the sire 
(n=59) which also indicated lack of independence with grandsire (p<.001).  
 
Discussion:  
The conventional wisdom holds that tongue lolling is familial. Our study clearly demonstrated 
that there is a genetic basis for the behavior but does not address potential environmental 
modifiers. Our method of identifying positive cows was specific but not sensitive as not all 
cows were observed.  
 
If tongue lolling is heritable, then environment may not be the sole cause for development of 
the behavior. 
13 
Name/Degrees: SallyAnne Ness, DVM         
 
Email: san56@cornell.edu 
 
Institution and location (Chronological)          Degree       Year 
Oregon State College of Veterinary Medicine, Corvallis     DVM     2008 
Cornell University, Ithaca, NY                     Residency 2010- 
              present 
 
Current Position: Resident, Large Animal Internal Medicine, 3rd year 
 
Abstract Title:  CLINICAL AND SEROLOGIC DIAGNOSIS OF BESNOITIOSIS IN 
DONKEYS 
 
Authors Names:  SallyAnne  Ness1, Gereon Schares2, Jeanine Peters1, Linda Mittel1, Jitender 
Dubey; Dwight  Bowman1, Hussni Mohammed1, Thomas Divers1 
 
1Cornell University, Ithaca, New York 
2 Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Wusterhausen, Germany 
3Animal Parasitic Diseases Laboratory, USDA, Beltsville, Maryland 
 
Project Mentor: Thomas J. Divers, Cornell University Department of Clinical Sciences 
 
Abstract: (< 250 words) 
Introduction: Besnoitiosis is an emerging infectious disease of donkeys in the United States 
caused by infection with the protozoan parasite Besnoitia bennetti. Clinical disease is 
characterized by miliary dermatitis with parasitic cysts in the skin, nares, and sclera. Currently 
the only method of diagnosis is histopathologic identification of Besnoitia organisms within 
tissues. 
 
Objective: The purpose of this study was to evaluate the utility of clinical examination and 
three serologic assays for the diagnosis of besnoitiosis in donkeys. 
 
Methods: A prospective study of 416 donkeys in 6 states was performed. Donkeys were 
examined for clinical lesions suggestive of besnoitiosis and evaluated for antibodies against B. 
bennetti using an immunofluorescent antibody (IFA) test and 2 immunoblot assays specific for 
bradyzoite and tachyzoite antigens, respectively. Donkeys confirmed to be infected with B. 
bennetti by histopathology (cases; n=32) were compared to those with no clinical signs of 
besnoitiosis (controls; n=384). 
 
Results: Identifying clinical lesions in 2 or more locations correctly identified infected 
donkeys 80% of the time. Donkeys with besnoitiosis had significantly higher IFA titers 
(P<.001) and numbers of bradyzoite (P<.001) and tachyzoite (P<.001) immunoblot bands than 
control donkeys. The sensitivity and specificity of the serologic assays for detecting 
besnoitiosis was 88% and 100% for IFA, 81% and 96% for bradyzoite immunoblot, and 90% 
and 100% for tachyzoite immunoblot, respectively. 
 
Discussion: Immunofluorescent antibody and immunoblot assays are effective at identifying 
donkeys with besnoitiosis and provide a more efficient and less invasive diagnostic alternative 
to histopathology. 
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Abstract:  
Objective: To compare the long-term outcome of tibial plateau leveling osteotomy (TPLO) 
and extracapsular repair (ECR) for treatment of a ruptured cranial cruciate ligament (RCCL).  
 
Study Design: Prospective clinical trial.  
 
Animals: Normal adult dogs (control, n = 79); dogs with unilateral CCL disease (n = 38).  
 
Methods: Dogs had TPLO (n = 15) or ECR (n = 23) for treatment of RCCL. Force plate gait 
analysis was performed for the control group at one time point and for treatment groups at 
serial points up to one year post-operatively. Symmetry indices (SIs) were calculated between 
pelvic limbs for ground reaction forces (GRFs), including peak vertical force (PVF), contact 
time (CT), and vertical impulse (VI). GRFs of the treatment and control groups were compared 
using a general linear model and Kaplan–Meier survival analysis.  
 
Results: At 8 weeks, for PVF and VI, the TPLO group had more symmetric limb loading than 
the ECR group at the walk and trot. SIs of the TPLO group were not different from the control 
group by 6 months to 1 year postoperatively. SIs for the ECR group were less symmetrical 
than the control group at all time periods. Using survival analysis, median time to normal 
function was no different at the walk between groups, but was shorter for the TPLO group for 
VI and PVF at the trot.  
 
Conclusions: Dogs achieved normal limb loading faster after TPLO than ECR. TPLO resulted 
in operated limb function that was indistinguishable from the control population by 1 year.  
